Article Versions Notes

Demoret B, Gregg J, Liebner DA, Tinoco G, Lenobel S, Chen JL. Prospective Evaluation of the Concordance of Commercial Circulating Tumor DNA Alterations with Tumor-Based Sequencing across Multiple Soft Tissue Sarcoma Subtypes. Cancers. 2019; 11(12):1829. https://doi.org/10.3390/cancers11121829

Demoret, Bryce, Jeff Gregg, David A. Liebner, Gabriel Tinoco, Scott Lenobel, and James L. Chen. 2019. "Prospective Evaluation of the Concordance of Commercial Circulating Tumor DNA Alterations with Tumor-Based Sequencing across Multiple Soft Tissue Sarcoma Subtypes" Cancers 11, no. 12: 1829. https://doi.org/10.3390/cancers11121829

Demoret, B., Gregg, J., Liebner, D. A., Tinoco, G., Lenobel, S., & Chen, J. L. (2019). Prospective Evaluation of the Concordance of Commercial Circulating Tumor DNA Alterations with Tumor-Based Sequencing across Multiple Soft Tissue Sarcoma Subtypes. Cancers, 11(12), 1829. https://doi.org/10.3390/cancers11121829